ArticleHaematologica2022

Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies.

Ronit Gurion et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.